VanderbiltHealth.com: For Patients and Visitors
Vanderbilt University Medical Center: For Employees, Researchers, and Students

2007-2008 Publications

*Illustrate inter- or intra-programmatic collaborations
+ and bold names: One of the ten best publications (PDF attached).

Acosta EP, Kendall MA, Gerber JG, Alston-Smith B, Koletar SL, Zolopa AR, Agarwala S, Child M, Bertz R, Hosey L, Haas DW. Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily. Antimicrob Agents Chemother. 2007 Sep;51(9):3104-10.

*Ambrose Z, Compton L, Piatak M Jr, Lu D, Alvord WG, Lubomirski MS, Hildreth JE, Lifson JD, Miller CJ, KewalRamani VN. Incomplete protection against simian immunodeficiency virus vaginal transmission in rhesus macaques by a topical antiviral agent revealed by repeat challenges. J Virol. 2008 Jul;82(13):6591-9.

Antons AK, Wang R, Oswald-Richter K, Tseng M, Arendt CW, Kalams SA, Unutmaz D. Naive precursors of human regulatory T cells require FoxP3 for suppression and are susceptible to HIV infection. J Immunol. 2008 Jan 15;180(2):764-73.

Baddley JW, Perfect JR, Oster RA, Larsen RA, Pankey GA, Henderson H, Haas DW,
Kauffman CA, Patel R, Zaas AK, Pappas PG. Pulmonary cryptococcosis in patients without HIV infection: factors associated with disseminated disease. Eur J Clin Microbiol Infect Dis. 2008 May 1.

Barrett TW, Schriger DL. Practical Considerations in HIV Testing in the Emergency Department, Characteristics of Diagnostic Tests, and the Role of Sensitivity Analysis in Observational Studies Answers to March 2008 Journal Club Questions. Ann Emerg Med. 2008 Aug;52(2):170-81.

*Bress JN, Hulgan T, Lyon JA, Johnston CP, Lehmann H, Sterling TR. Agreement of decision analyses and subsequent clinical studies in infectious diseases. Am J Med. 2007 May;120(5):461.e1-9.

+*Canter JA, Haas DW, Kallianpur AR, Ritchie MD, Robbins GK, Shafer RW, Clifford DB, Murdock DG, Hulgan T. The mitochondrial pharmacogenomics of haplogroup T: MTND2*LHON4917G and antiretroviral therapy-associated peripheral neuropathy. Pharmacogenomics J. 2008 Feb;8(1):71-7.

Carlisle J, Evans W, Hajizadeh R, Nadaf M, Shepherd B, Ott RD, Richter K, Drake W. Multiple Mycobacterium antigens induce interferon-gamma production from sarcoidosis peripheral blood mononuclear cells. Clin Exp Immunol. 2007 Dec;150(3):460-8.

Carlucci JG, Kamanga A, Sheneberger R, Shepherd BE, Jenkins CA, Spurrier J, Vermund SH. Predictors of adherence to antiretroviral therapy in rural Zambia. J Acquir Immune Defic Syndr. 2008 Apr 15;47(5):615-22.

Cover TL. Beta2 integrin mediates entry of a bacterial toxin into T lymphocytes. Cell Host Microbe. 2008 Jan 17;3(1):5-6.

+Donahue JP, Vetter ML, Mukhtar NA, D'Aquila RT. The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation. Virology. 2008 Jul 20;377(1):49-53.

Dukes Hamilton C, Sterling TR, Blumberg HM, Leonard M, McAuley J, Schlossberg D, Stout J, Huitt G. Extensively drug-resistant tuberculosis: are we learning from history or repeating it? Clin Infect Dis. 2007 Aug 1;45(3):338-42.

*El-Bejjani D, Hazen SL, Mackay W, Glass NE, Hulgan T, Tungsiripat M, McComsey GA. Higher plasma myeloperoxidase levels are not associated with an increased risk for cardiovascular events in HIV-infected adults. HIV Clin Trials. 2008 May-Jun;9(3):207-11.

Gaba PD, Haley C, Griffin MR, Mitchel E, Warkentin J, Holt E, Baggett P, Sterling TR. Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease. Arch Intern Med. 2007 Nov 26;167(21):2317-22.

*Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, Brooks JT, Calzavara L, Deeks SG, Eron JJ, Gebo KA, Gill MJ, Haas DW, Hogg RS, Horberg MA, Jacobson LP, Justice AC, Kirk GD, Klein MB, Martin JN, McKaig RG, Rodriguez B, Rourke SB, Sterling TR, Freeman AM, Moore RD. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol. 2007 Apr;36(2):294-301.

*Gardner LI, Marks G, O'Daniels CM, Wilson TE, Golin C, Wright J, Quinlivan EB, Bradley-Springer L, Thompson M, Raffanti S, Thrun M. Implementation and Evaluation of a Clinic-Based Behavioral Intervention: Positive Steps for Patients with HIV. AIDS Patient Care STDS. 2008 Jul 15. [Epub ahead of print]

Hare CB, Mellors J, Krambrink A, Su Z, Skiest D, Margolis DM, Patel SS, Barnas D, Frenkel L, Coombs RW, Aweeka F, Morse GD, Haas DW, Boltz V, Palmer S, Coffin J, Havlir DV. Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy. Clin Infect Dis. 2008 Aug 1;47(3):421-4.

+*Hulgan T, Klausner JD. Phosphodiesterase type-5 inhibitors and the reemerging HIV epidemic. JAMA. 2008 Mar 26;299(12):1426.

+*Hulgan T, Tebas P, Canter JA, Mulligan K, Haas DW, Dubé M, Grinspoon S,
Robbins GK, Motsinger AA, Kallianpur AR; AIDS Clinical Trials Group 384 and
A5005s Study Teams. Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy. J Infect Dis. 2008 Mar 15;197(6):858-66.

Jia Y, Lu F, Sun X, Vermund SH. Sources of data for improved surveillance of HIV/AIDS in China. Southeast Asian J Trop Med Public Health. 2007 Nov;38(6):1041-52.

Kallewaard NL, McKinney BA, Gu Y, Chen A, Prasad BV, Crowe JE Jr. Functional maturation of the human antibody response to rotavirus. J Immunol. 2008 Mar 15;180(6):3980-9.

Kang Y, Li D, Kalams SA, Eid JE. DC-Dielectrophoretic separation of biological cells by size. Biomed Microdevices. 2008 Apr;10(2):243-9.

Kitabwalla M, Ansari AA, Villinger F, Akeefe H, Conner AP, Mayne AE, Hildreth JE. Delipidated retroviruses as potential autologous therapeutic vaccines--a pilot experiment. Exp Biol Med (Maywood). 2008 Jun;233(6):732-40.

Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008 Feb 1;197(3):411-9.

Koethe JR, Moore RD, Wagner KR. Physician specialization and women's primary care services in an urban HIV clinic. AIDS Patient Care STDS. 2008 May;22(5):373-80.

Kuritzkes DR, Lalama CM, Ribaudo HJ, Marcial M, Meyer WA 3rd, Shikuma C, Johnson VA, Fiscus SA, D'Aquila RT, Schackman BR, Acosta EP, Gulick RM. Preexisting resistance to nonnucleoside reverse-transcriptase inhibitors predicts virologic failure of an efavirenz-based regimen in treatment-naive HIV-1-infected subjects. J Infect Dis. 2008 Mar 15;197(6):867-70.

Levine RS, Briggs NC, Kilbourne BS, King WD, Fry-Johnson Y, Baltrus PT,
Husaini BA, Rust GS. Black-White mortality from HIV in the United States before and after introduction of highly active antiretroviral therapy in 1996. Am J Public Health. 2007 Oct;97(10):1884-92.

Maddux DE, Reibero PF, Kheshti A, Sterling TR, Raffanti SP. Misdiagnosis of HIV infection: implications for universal testing. AIDS. 2008 Feb 19;22(4):546-7.

*McGowan CC, Cahn P, Gotuzzo E, Padgett D, Pape JW, Wolff M, Schechter M, Masys DR. Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme. Int J Epidemiol. 2007 Oct;36(5):969-76.

Mok H, Lee S, Wright DW, Crowe JE Jr. Enhancement of the CD8(+) T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope. Vaccine. 2008 Jul 25. [Epub ahead of print]

+Motsinger AA, Haas DW, Hulgan T, Ritchie MD. Human genomic association studies: a primer for the infectious diseases specialist. J Infect Dis. 2007 Jun 15;195(12):1737-44.

Pepper T, Joseph P, Mwenya C, McKee GS, Haushalter A, Carter A, Warkentin J, Haas DW, Sterling TR. Normal chest radiography in pulmonary tuberculosis: implications for obtaining respiratory specimen cultures. Int J Tuberc Lung Dis. 2008 Apr;12(4):397-403.

Qi M, Aiken C. Nef enhances HIV-1 infectivity via association with the virus assembly complex. Virology. 2008 Apr 10;373(2):287-97.

+*Rebeiro PF, Kheshti A, Bebawy SS, Stinnette SE, Erdem H, Tang Y, Sterling TR, Raffanti SP, D’Aquila RT. Increased Detectability of Plasma HIV-1 RNA After Introduction of a New Assay and Altered Specimen Processing Procedures. Clin Infect. Diseases, In Press.

Riddler SA, Jiang H, Tenorio A, Huang H, Kuritzkes DR, Acosta EP, Landay A, Bastow B, Haas DW, Tashima KT, Jain MK, Deeks SG, Bartlett JA. A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115. Antivir Ther. 2007;12(4):531-41.

Riviello ED, Sterling TR, Shepherd B, Fantan T, Makhema J. HIV in the workplace in Botswana: incidence, prevalence, and disease severity. AIDS Res Hum Retroviruses. 2007 Dec;23(12):1453-60.

+Rold CJ, Aiken C. Proteasomal degradation of TRIM5alpha during retrovirus restriction. PLoS Pathog. 2008 May 23;4(5):e1000074.

*Sadagopal S, Lorey S, Barnett L, Basham R, Lebo L, Erdem H, Haas DW, Kalams SA (2007) Higher relative frequencies of HIV-specific CD8+ T cells in cerebrospinal fluid (CSF) versus peripheral blood in antiretroviral-naive immune controllers. Presented at 8th International Symposium on NeuroVirology. San Diego, CA, October 2007 (Abstract P-145) J Neurovirol 13(suppl 1), 2007.

Schiffer JT, Sterling TR. Timing of antiretroviral therapy initiation in tuberculosis patients with AIDS: a decision analysis. J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):229-34.

*Schneidewind A, Brockman MA, Yang R, Adam RI, Li B, Le Gall S, Rinaldo CR, Craggs SL, Allgaier RL, Power KA, Kuntzen T, Tung CS, LaBute MX, Mueller SM, Harrer T, McMichael AJ, Goulder PJ, Aiken C, Brander C, Kelleher AD, Allen TM. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. J Virol. 2007 Nov;81(22):12382-93.

Scorpio DG, Ruben DS, Liao Z, Hildreth JE, Fletcher CA. Cervicovaginal evaluation in macaques used as a model for topical microbicide safety studies. J Med Primatol. 2008 Feb;37 Suppl 1:65-73.

Shankar SM, Nania JJ. Management of Pneumocystis jiroveci pneumonia in children receiving chemotherapy. Paediatr Drugs. 2007;9(5):301-9.

Shepherd BE. The cost of checking proportional hazards. Stat Med. 2008 Apr 15;27(8):1248-60.

Simons BC, VanCompernolle SA, Smith RM, Wei J, Barnett L, Lorey SL, Meyer-Olson D, Kalams SA. Biased T cell receptor gene usage of an immunodominant epitope-specific CD8 T cell population. Journal of Immunology, In Press

Song C, Aiken C. Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant. J Virol. 2007 Nov;81(21):11946-56.

Srinivasakumar N. Substitution of the Rev-response element in an HIV-1-based gene delivery system with that of SIVmac239 allows efficient delivery of Rev M10 into T-lymphocytes. AIDS Res Ther. 2008 Jun 5;5:11.

*Sterling TR, Martire T, de Almeida AS, Ding L, Greenberg DE, Moreira LA, Elloumi H, Torres AP, Sant'Anna CC, Calazans E, Paraguassu G, Gebretsadik T, Shintani A, Miller K, Kritski A, Lapa e Silva JR, Holland SM. Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination. Pediatrics. 2007 Oct;120(4):e912-21.

+*Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis. 2007 Oct 1;196(7):1044-52.

Tian C, Luskin GK, Dischert KM, Higginbotham JN, Shepherd BE, Crowe JE Jr. Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J Immunol. 2008 Mar 1;180(5):3279-88.

Tsai CS, Shepherd BE, Vermund SH. Does douching increase risk for sexually transmitted infections? A prospective study in high-risk adolescents. Am J Obstet Gynecol. 2008 Jul 28. [Epub ahead of print]

+*Varthakavi V, Heimann-Nichols E, Smith RM, Sun Y, Bram RJ, Ali S, Rose J, Ding L, Spearman P. Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu. Nat Med. 2008 Jun;14(6):641-7.

Vermund SH, Sahasrabuddhe VV, Khedkar S, Jia Y, Etherington C, Vergara A. Building global health through a center-without-walls: the Vanderbilt Institute for Global Health. Acad Med. 2008 Feb;83(2):154-64.

Vermund SH, Yamamoto N. Co-infection with human immunodeficiency virus and tuberculosis in Asia. Tuberculosis (Edinb). 2007 Aug;87 Suppl 1:S18-25.

+Vetter ML, Johnson ME, Antons AK, Unutmaz D, D’Aquila RT. Differences in APOBEC3G Expression in
CD4+ T Helper Lymphocyte Subtypes Modulate HIV-1 Infectivity. PLoS Pathogens, Provisionally Accepted

Wagner LJ, Hilker KA, Hepworth JT, Wallston KA. Cognitive Adaptability as a Moderator of Expressive Writing Effects in an HIV Sample. AIDS Behav. 2008 Jul 8.

+*Wang YN, Kang Y, Xu D, Chon CH, Barnett L, Kalams SA, Li D, Li D. On-chip counting the number and the percentage of CD4+ T lymphocytes. Lab Chip. 2008 Feb;8(2):309-15.

Yu X, McGraw PA, House FS, Crowe JE Jr. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods. 2008 Jul 31;336(2):142-51.

Zong JC, Arav-Boger R, Alcendor DJ, Hayward GS. Reflections on the interpretation of heterogeneity and strain differences based on very limited PCR sequence data from Kaposi's sarcoma-associated herpesvirus genomes. J Clin Virol. 2007 Sep;40(1):1-8.

Copyright © 2014 by Vanderbilt University Medical Center    |    1211 Medical Center Drive    |    Nashville, TN 37232    |    (615) 322-5000
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
This page was last updated September 20, 2011 and is maintained by Gina Perez